Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
Surgery|October 11, 2005
Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cellsYoung-Jin Suh, Sunil Chada, Tamra McKenzie, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2025
Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast CancerJennifer H Chen, Rebecca S Slack Tidwell, Megumi Kai, et al.
Plos One|October 4, 2014
Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agentsBalraj Singh, Anna Shamsnia, Milan R Raythatha, et al.
Annals of Surgical Oncology|July 21, 2023
Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal TherapyTaiwo Adesoye, Shlermine Everidge, Jennifer Chen, et al.
Cancers|June 23, 2019
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal MelanomaKartik Anand, Jason Roszik, Dan Gombos, et al.
Molecular and Clinical Oncology|July 24, 2014
Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patientsKailash Mosalpuria, Carolyn Hall, Savitri Krishnamurthy, et al.
American Journal of Surgery|September 17, 2005
Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel nodeNazanin Khakpour, Kelly K Hunt, Henry M Kuerer, et al.
Melanoma Research|May 27, 2015
Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary studyChristina L Roland, Merrick I Ross, Carolyn S Hall, et al.
Clinical & Experimental Metastasis|March 16, 2010
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancerBalraj Singh, Kendra R Cook, Cecilia Martin, et al.
The Journal of Surgical Research|May 24, 2008
Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cellsBalraj Singh, Kendra R Cook, Laura Vincent, et al.
Pageof 21